AKBA FY 2016 Earnings — Akebia Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

AKBAAkebia Therapeutics, Inc.

$366M

FY 2016 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$2M

Gross Profit

-$114M-7443.0% margin

Operating Income

-$136M-8889.9% margin

Net Income

-$136M-8843.5% margin

EPS (Diluted)

$-3.60

Cash Flow

Operating Cash Flow

$58M

Free Cash Flow

$55M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$300M

Total Liabilities

$232M

Stockholders' Equity

$68M

Cash & Equivalents

$187M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2M	$0	—
Gross Profit	-$114M	-$96,000	-118910.4%
Operating Income	-$136M	-$62M	-121.8%
Net Income	-$136M	-$61M	-123.6%